FRTX logo

FRTX Total Liabilities

Annual Total Liabilities

$1.66 M
-$1.42 M-46.18%

December 31, 2023


Summary


Performance

FRTX Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFRTXbalance sheetmetrics:

Quarterly Total Liabilities

$1.66 M
-$452.00 K-21.44%

December 31, 2023


Summary


Performance

FRTX Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFRTXbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

FRTX Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-46.2%-21.4%
3 y3 years-74.5%-21.4%
5 y5 years-53.8%-21.4%

FRTX Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-65.6%at low-65.6%at low
5 y5-year-84.3%at low-84.3%at low
alltimeall time-92.1%+38.0%-92.4%+42.9%

Fresh Tracks Therapeutics Total Liabilities History

DateAnnualQuarterly
Dec 2023
$1.66 M(-46.2%)
$1.66 M(-21.4%)
Sep 2023
-
$2.11 M(+13.9%)
Jun 2023
-
$1.85 M(-11.9%)
Mar 2023
-
$2.10 M(-31.7%)
Dec 2022
$3.08 M(-36.0%)
$3.08 M(-4.6%)
Sep 2022
-
$3.22 M(+12.3%)
Jun 2022
-
$2.87 M(-39.5%)
Mar 2022
-
$4.74 M(-1.4%)
Dec 2021
$4.81 M(-26.0%)
-
Dec 2021
-
$4.81 M(+14.0%)
Sep 2021
-
$4.22 M(-37.2%)
Jun 2021
-
$6.72 M(-30.8%)
Mar 2021
-
$9.71 M(+49.4%)
Dec 2020
$6.50 M(-38.5%)
$6.50 M(-15.5%)
Sep 2020
-
$7.69 M(+2.3%)
Jun 2020
-
$7.52 M(+5.3%)
Mar 2020
-
$7.14 M(-32.4%)
Dec 2019
$10.57 M(+195.2%)
$10.57 M(-19.6%)
Sep 2019
-
$13.14 M(+1034.1%)
Jun 2019
-
$1.16 M(-54.0%)
Mar 2019
-
$2.52 M(-29.6%)
Dec 2018
$3.58 M(-78.8%)
$3.58 M(+1.4%)
Sep 2018
-
$3.53 M(+11.0%)
Jun 2018
-
$3.18 M(+0.8%)
Mar 2018
-
$3.16 M(-81.3%)
Dec 2017
$16.92 M(+136.8%)
$16.92 M(+42.4%)
Sep 2017
-
$11.88 M(+8.2%)
Jun 2017
-
$10.98 M(+24.0%)
Mar 2017
-
$8.86 M(+23.9%)
Dec 2016
$7.14 M(+58.0%)
$7.14 M(+80.2%)
Sep 2016
-
$3.96 M(+16.5%)
Jun 2016
-
$3.40 M(-11.7%)
Mar 2016
-
$3.85 M(-14.8%)
Dec 2015
$4.52 M(-25.4%)
$4.52 M(-24.2%)
Sep 2015
-
$5.97 M(+15.6%)
Jun 2015
-
$5.16 M(+6.1%)
Mar 2015
-
$4.87 M(-19.7%)
Dec 2014
$6.06 M(+22.6%)
$6.06 M(+7.9%)
Sep 2014
-
$5.61 M(+15.2%)
Jun 2014
-
$4.87 M(+7.9%)
Mar 2014
-
$4.52 M(-8.6%)
Dec 2013
$4.94 M(-33.6%)
$4.94 M(-25.1%)
Sep 2013
-
$6.60 M(-12.5%)
Jun 2013
-
$7.54 M(+10.2%)
Mar 2013
-
$6.84 M(-7.9%)
Dec 2012
$7.44 M(-11.7%)
$7.44 M(+1.4%)
Sep 2012
-
$7.33 M(+6.5%)
Jun 2012
-
$6.88 M(-24.8%)
Mar 2012
-
$9.16 M(+8.7%)
Dec 2011
$8.43 M(-1.4%)
$8.43 M(+12.0%)
Sep 2011
-
$7.52 M(-3.2%)
Jun 2011
-
$7.77 M(+2.3%)
Mar 2011
-
$7.59 M(-11.2%)
Dec 2010
$8.54 M(-31.0%)
$8.54 M(-6.7%)
Sep 2010
-
$9.15 M(-0.7%)
Jun 2010
-
$9.22 M(-9.7%)
Mar 2010
-
$10.20 M(-17.7%)
Dec 2009
$12.39 M(+18.6%)
$12.39 M(+4.2%)
Sep 2009
-
$11.89 M(+4.7%)
Jun 2009
-
$11.36 M(+9.6%)
Mar 2009
-
$10.37 M(-0.7%)
Dec 2008
$10.44 M
$10.44 M(+4.4%)
Sep 2008
-
$10.00 M(-0.6%)
Jun 2008
-
$10.07 M(+18.7%)
DateAnnualQuarterly
Mar 2008
-
$8.48 M(-20.5%)
Dec 2007
$10.67 M(-4.1%)
$10.67 M(+26.8%)
Sep 2007
-
$8.42 M(+2.2%)
Jun 2007
-
$8.23 M(-13.6%)
Mar 2007
-
$9.53 M(-14.3%)
Dec 2006
$11.13 M(-21.8%)
$11.13 M(+7.7%)
Sep 2006
-
$10.33 M(-1.5%)
Jun 2006
-
$10.49 M(-14.4%)
Mar 2006
-
$12.26 M(-13.8%)
Dec 2005
$14.22 M(-22.3%)
$14.22 M(-5.6%)
Sep 2005
-
$15.07 M(-8.5%)
Jun 2005
-
$16.47 M(+3.6%)
Mar 2005
-
$15.90 M(-13.2%)
Dec 2004
$18.32 M(-12.3%)
$18.32 M(+7.5%)
Sep 2004
-
$17.04 M(-13.1%)
Jun 2004
-
$19.62 M(-9.7%)
Mar 2004
-
$21.73 M(+4.1%)
Dec 2003
$20.89 M(+38.1%)
$20.89 M(-1.4%)
Sep 2003
-
$21.19 M(-2.9%)
Jun 2003
-
$21.83 M(+52.1%)
Mar 2003
-
$14.35 M(-5.1%)
Dec 2002
$15.12 M(+22.6%)
$15.12 M(+15.2%)
Sep 2002
-
$13.13 M(+8.2%)
Jun 2002
-
$12.14 M(+11.7%)
Mar 2002
-
$10.87 M(-11.9%)
Dec 2001
$12.34 M(+1.9%)
$12.34 M(-7.9%)
Sep 2001
-
$13.39 M(+6.4%)
Jun 2001
-
$12.58 M(+1.7%)
Mar 2001
-
$12.37 M(+2.2%)
Dec 2000
$12.11 M(+89.2%)
$12.11 M(+13.3%)
Sep 2000
-
$10.69 M(-8.9%)
Jun 2000
-
$11.74 M(+9.1%)
Mar 2000
-
$10.76 M(+68.1%)
Dec 1999
$6.40 M(+60.0%)
$6.40 M(+28.0%)
Sep 1999
-
$5.00 M(+8.7%)
Jun 1999
-
$4.60 M(+4.5%)
Mar 1999
-
$4.40 M(+10.0%)
Dec 1998
$4.00 M(+14.3%)
$4.00 M(+8.1%)
Sep 1998
-
$3.70 M(-2.6%)
Jun 1998
-
$3.80 M(+15.2%)
Mar 1998
-
$3.30 M(-5.7%)
Dec 1997
$3.50 M(-12.5%)
$3.50 M(+12.9%)
Sep 1997
-
$3.10 M(-6.1%)
Jun 1997
-
$3.30 M(-5.7%)
Mar 1997
-
$3.50 M(-12.5%)
Dec 1996
$4.00 M(+122.2%)
$4.00 M(+2.6%)
Sep 1996
-
$3.90 M(+50.0%)
Jun 1996
-
$2.60 M(+62.5%)
Mar 1996
-
$1.60 M(-11.1%)
Dec 1995
$1.80 M(-25.0%)
$1.80 M(-5.3%)
Sep 1995
-
$1.90 M(+26.7%)
Jun 1995
-
$1.50 M(-16.7%)
Mar 1995
-
$1.80 M(-25.0%)
Dec 1994
$2.40 M(-11.1%)
$2.40 M(+4.3%)
Sep 1994
-
$2.30 M(0.0%)
Jun 1994
-
$2.30 M(+15.0%)
Mar 1994
-
$2.00 M(-25.9%)
Dec 1993
$2.70 M(-20.6%)
$2.70 M(+8.0%)
Sep 1993
-
$2.50 M(-16.7%)
Jun 1993
-
$3.00 M(+87.5%)
Mar 1993
-
$1.60 M(-52.9%)
Dec 1992
$3.40 M(+112.5%)
$3.40 M(+112.5%)
Dec 1991
$1.60 M(+33.3%)
$1.60 M(+33.3%)
Dec 1990
$1.20 M
$1.20 M

FAQ

  • What is Fresh Tracks Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Fresh Tracks Therapeutics?
  • What is Fresh Tracks Therapeutics annual total liabilities year-on-year change?
  • What is Fresh Tracks Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Fresh Tracks Therapeutics?
  • What is Fresh Tracks Therapeutics quarterly total liabilities year-on-year change?

What is Fresh Tracks Therapeutics annual total liabilities?

The current annual total liabilities of FRTX is $1.66 M

What is the all time high annual total liabilities for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high annual total liabilities is $20.89 M

What is Fresh Tracks Therapeutics annual total liabilities year-on-year change?

Over the past year, FRTX annual total liabilities has changed by -$1.42 M (-46.18%)

What is Fresh Tracks Therapeutics quarterly total liabilities?

The current quarterly total liabilities of FRTX is $1.66 M

What is the all time high quarterly total liabilities for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high quarterly total liabilities is $21.83 M

What is Fresh Tracks Therapeutics quarterly total liabilities year-on-year change?

Over the past year, FRTX quarterly total liabilities has changed by -$452.00 K (-21.44%)